Loss-of-heterozygosity on chromosome 19q in early-stage serous ovarian cancer is associated with recurrent disease

Ingiridur Skirnisdottir, Markus Mayrhofer, Maria Rydåker, Helena Åkerud, Anders Isaksson

Open source

DOI
10.1186/1471-2407-12-407
Published
2012-09-12
Container
BMC Cancer
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/1471-2407-12-407,
  title = {Loss-of-heterozygosity on chromosome 19q in early-stage serous ovarian cancer is associated with recurrent disease},
  author = {Ingiridur Skirnisdottir and Markus Mayrhofer and Maria Rydåker and Helena Åkerud and Anders Isaksson},
  year = {2012},
  journal = {BMC Cancer},
  doi = {10.1186/1471-2407-12-407},
  url = {https://doi.org/10.1186/1471-2407-12-407}
}

RIS

TY  - JOUR
TI  - Loss-of-heterozygosity on chromosome 19q in early-stage serous ovarian cancer is associated with recurrent disease
AU  - Ingiridur Skirnisdottir
AU  - Markus Mayrhofer
AU  - Maria Rydåker
AU  - Helena Åkerud
AU  - Anders Isaksson
PY  - 2012
JO  - BMC Cancer
DO  - 10.1186/1471-2407-12-407
UR  - https://doi.org/10.1186/1471-2407-12-407
ER  - 

APA

Skirnisdottir, I., Mayrhofer, M., Rydåker, M., Åkerud, H., & Isaksson, A. (2012). Loss-of-heterozygosity on chromosome 19q in early-stage serous ovarian cancer is associated with recurrent disease. BMC Cancer. https://doi.org/10.1186/1471-2407-12-407

Source records